Donanemab

Generic Name
Donanemab
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1931944-80-7
Unique Ingredient Identifier
1ADB65P1KK
Background

Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody targeted against an epitope at the N-terminal of a specific type of amyloid beta (Aβ) - pyroglutamate Aβ - which is found only in the brain amyloid plaques associated with Alzheimer's Disease (AD). It works by inducing microglial-mediated clearance of existing Aβ plaques with the intent of slowing...

Indication

用于治疗阿尔茨海默病。

Associated Conditions
-
Associated Therapies
-
© Copyright 2024. All Rights Reserved by MedPath